Inhibition of angiotensin II-induced cardiac hypertrophy and associated ventricular arrhythmias by a p21 activated kinase 1 bioactive peptide

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Wang, Rui ^a   Wang, Yanwen ^b,c   Lin, Wee K ^c   Zhang, Yanmin ^b   Liu, Wei ^b   Huang, Kai ^a   Terrar, Derek A ^c   Solaro, R John ^d   Wang, Xin ^b   Ke, Yunbo ^d   Lei, Ming ^a,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANTIARRHYTHMIC AGENT; CALCIUM ION; P21 ACTIVATED KINASE 1; PAK ACTIVATING PEPTIDE; UNCLASSIFIED DRUG; P21 ACTIVATED KINASE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; RAT; ANIMAL; ARRHYTHMIAS, CARDIAC; C57BL MOUSE; CARDIOMEGALY; CELL CULTURE; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; METABOLISM; MOUSE;

ANGIOTENSIN II; ANIMALS; ARRHYTHMIAS, CARDIAC; CARDIOMEGALY; CELLS, CULTURED; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; P21-ACTIVATED KINASES; PEPTIDES; RATS;

EID: 84904246339     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101974     Document Type: Article

References (20)

1. McKinsey TA, Kass DA (2007) Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface. Nat Rev Drug Discov 6: 617-635. (Pubitemid 47207749)
2. Ke Y, Wang L, Pyle WG, de Tombe PP, Solaro RJ (2004) Intracellular Localization and Functional Effects of P21-Activated Kinase-1 (Pak1) in Cardiac Myocytes. Circ Res 94: 194-200. (Pubitemid 38197451)
3. Ke Y, Lei M, Collins TP, Rakovic S, Mattick PAD, et al. (2007) Regulation of L-Type Calcium Channel and Delayed Rectifier Potassium Channel Activity by p21-Activated Kinase-1 in Guinea Pig Sinoatrial Node Pacemaker Cells. Circ Res 100: 1317-1327. (Pubitemid 46742922)
4. Ke Y, Lei M, Solaro RJ (2008) Regulation of cardiac excitation and contraction by p21 activated kinase-1. Prog Biophys Mol Biol 98: 238-250.
5. Ke Y, Lei M, Collins TP, Rakovic S, Mattick PA, et al. (2007) Regulation of L-type calcium channel and delayed rectifier potassium channel activity by p21-activated kinase-1 in guinea pig sinoatrial node pacemaker cells. Circ Res 100: 1317-1327. (Pubitemid 46742922)
6. Liu W, Min Z, Naumann R, Ke Y, Ulm S, et al. (2011) PAK1 is a novel signal transducer attenuating cardiac hypertrophy. Circulation 124(24):2702-15: 2702-2715.
7. Taglieri DM, Monasky MM, Knezevic I, Sheehan KA, Lei M, et al. (2011) Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A. J Mol Cell Cardiol 51: 988-996.
8. Zipes DP, Wellens HJJ (1998) Sudden Cardiac Death. Circulation 98: 2334-2351. (Pubitemid 28533855)
9. Saffitz JE, Schuessler RB, Yamada KA (1999) Mechanisms of remodeling of gap junction distributions and the development of anatomic substrates of arrhythmias. Cardiovasc Res 42: 309-317. (Pubitemid 29243159)
10. Qu J, Volpicelli FM, Garcia LI, Sandeep N, Zhang J, et al. (2009) Gap Junction Remodeling and Spironolactone-Dependent Reverse Remodeling in the Hypertrophied Heart. Circ Res 104: 365-371.
11. Emdad L, Uzzaman M, Takagishi Y, Honjo H, Uchida T, et al. (2001) Gap Junction Remodeling in Hypertrophied Left Ventricles of Aortic-banded Rats: Prevention by Angiotensin II Type 1 Receptor Blockade. J Mol Cell Cardiol 33: 219-231. (Pubitemid 32537922)
12. Bers DM (2008) Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol. 70: 23-49.
13. Beeser A, Chernoff J (2005) Production and use of a cell permeable inhibitor of group A Paks (TAT-PID) to analyze signal transduction. Methods 37: 203-207. (Pubitemid 41587430)
14. Thullberg M, Gad A, Beeser A, Chernoff J, Stromblad S (2006) The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activity. Oncogene 26: 1820-1828.
15. Delorme-Walker VD, Peterson JR, Chernoff J, Waterman CM, Danuser G, et al. (2011) Pak1 regulates focal adhesion strength, myosin IIA distribution, and actin dynamics to optimize cell migration. J Cell Biol 193: 1289-1303.
16. Manser E, Huang HY, Loo TH, Chen XQ, Dong JM, et al. (1997) Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol 17: 1129-1143. (Pubitemid 27097342)
17. Thullberg M, Gad A, Beeser A, Chernoff J, Stromblad S (2007) The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activity. Oncogene 26: 1820-1828. (Pubitemid 46426207)
18. Sheridan DJ, Kingsbury MP, Flores NA (1999) Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives? Br J Clin Pharmacol 47: 125-130. (Pubitemid 29078010)
19. Ai X, Jiang A, Ke Y, Solaro RJ, Pogwizd SM (2011) Enhanced activation of p21-activated kinase 1 in heart failure contributes to dephosphorylation of connexin 43. Cardiovasc Res 92: 106-114.
20. Ai Z, Fischer A, Spray DC, Brown AMC, Fishman GI (2000) Wnt-1 regulation of connexin43 in cardiac myocytes. J Clin Invest 105: 161-171. (Pubitemid 30054355)